Senior editor Irene Jarchum talks to Cliona Rooney about a recent paper in which Mark Cobbold and colleagues describe an antibody-mediated strategy to retarget virus-specific T cells against tumors. The paper was published in Nature Biotechnology; it can be read at https://doi.org/10.1038/s41587-019-0404-8.

https://aca.st/d83f22